Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Trump Opioid Plan Includes Death Penalty for Traffickers

By DARLENE SUPERVILLE, AP | March 19, 2018

In this Friday, Oct. 6, 2017, file photo, President Donald Trump speaks during an event at the White House in Washington, as first lady Melania Trump listens. Trump’s plan to combat opioid drug addiction calls for stiffer penalties for drug traffickers, including the death penalty where it’s appropriate under current law. The president is scheduled to unveil his plan Monday, March 19, 2018, in New Hampshire, a state hard-hit by the crisis. He’ll be accompanied by first lady Melania Trump, who has shown an interest in the issue, particularly as it pertains to children. (AP Photo/Evan Vucci, File)

President Donald Trump’s plan to combat opioid drug addiction nationwide calls for stiffer penalties for drug traffickers, including the death penalty where appropriate under current law, a top administration official said. It’s a fate for drug dealers that Trump, who aims to be seen as tough on crime, has been highlighting publicly in recent weeks.

Trump also wants Congress to pass legislation reducing the amount of drugs needed to trigger mandatory minimum sentences for traffickers who knowingly distribute certain illicit opioids, said Andrew Bremberg, Trump’s domestic policy director, who briefed reporters Sunday on the plan Trump is scheduled to unveil Monday in New Hampshire, a state hard-hit by the crisis.

The president will be joined by first lady Melania Trump, who has shown an interest in the issue, particularly as it pertains to her focus on child welfare.

Death for drug traffickers and mandatory minimum penalties for distributing certain opioids are just two elements under the part of Trump’s plan that deals with law enforcement and interdiction to break the international and domestic flow of drugs into and across the U.S.

Other parts of the plan include broadening education and awareness, and expanding access to proven treatment and recovery efforts.

Trump has mused openly in recent weeks about subjecting drug dealers to the “ultimate penalty.”

The president told the audience at a Pennsylvania campaign rally this month that countries like Singapore have fewer issues with drug addiction because they harshly punish their dealers. He argued that a person in the U.S. can get the death penalty or life in prison for shooting one person, but that a drug dealer who potentially kills thousands can spend little or no time in jail.

“The only way to solve the drug problem is through toughness,” Trump said in Moon Township.

He made similar comments at a recent White House summit on opioids. “Some countries have a very, very tough penalty — the ultimate penalty. And, by the way, they have much less of a drug problem than we do,” Trump said. “So we’re going to have to be very strong on penalties.”

The Justice Department said the federal death penalty is available for several limited drug-related offenses, including violations of the “drug kingpin” provisions of federal law.

Doug Berman, a law professor at Ohio State University, said it was not clear that death sentences for drug dealers, even for those whose product causes multiple deaths, would be constitutional. Berman said the issue would be litigated extensively and would have to be definitively decided by the U.S. Supreme Court.

Opioids, including prescription opioids, heroin and synthetic drugs such as fentanyl, killed more than 42,000 people in the U.S. in 2016, more than any year on record, according to the Centers for Disease Control and Prevention. Trump has declared that fighting the epidemic is a priority for the administration but critics say the effort has fallen short.

Last October, Trump declared the crisis a national public health emergency, short of the national state of emergency sought by a presidential commission he put together to study the issue.

“We call it the crisis next door because everyone knows someone,” said Kellyanne Conway, a Trump senior adviser. “This is no longer somebody else’s community, somebody else’s kid, somebody else’s co-worker.”

Other elements of the plan Trump will discuss Monday call for a nationwide public awareness campaign, which Trump announced last October, and increased research and development through public-private partnerships between the federal National Institutes of Health and pharmaceutical companies.

Bremberg said the administration also has a plan to cut the number of filled opioid prescriptions by one-third within three years.

The stop in New Hampshire will be Trump’s first visit as president. He won the state’s 2016 Republican presidential primary but narrowly lost in the general election to Hillary Clinton. It follows a visit to the state last week by retiring Sen. Jeff Flake, R-Ariz., a persistent Trump critic. Flake told New Hampshire Republicans that someone needs to stop Trump — and it could be him if no one else steps up.


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE